New Delhi [India], June 4 (ANI): The only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatment of COVID-19 has been recommended to conduct clinical trials by the Subject Expert Committee (SEC) of Central Drug
New Delhi [India], June 3 (ANI): A Delhi Hospital on Tuesday pulled two high-risk senior citizen COVID-19 patients out of danger by administering Monoclonal Antibody Cocktail (MAC) therapy.
New Delhi [India], June 1 (ANI): Delhi's Sir Gangaram Hospital on Tuesday commenced administration of Monoclonal Antibody Cocktail (MAC) to coronavirus patients, the medical facility said in a statement.
New Delhi [India], June 1 (ANI): Eli Lilly and Company India on Tuesday announced that it has received emergency use approval in the country for its monoclonal antibody drug combination used for treating Covid-19 patients with mild to moderate symptoms.
New Delhi [India], June 1 (ANI): Eli Lilly and Company India said on Tuesday it has received permission for restricted emergency use of its antibody drugs bamlanivimab 700 mg and etesevimab 1,400 mg in India for treatment of patients with mild to moderate coronavirus disease 2019 (Covid-19).
New Delhi [India], June 1 (ANI): Remembering his late mother Nargis Dutt on what would have been her 92nd birth anniversary, Bollywood star Sanjay Dutt shared priceless monochromatic pictures from his family album on social media.
New Delhi [India], May 31 (ANI): Monoclonal antibodies, recently introduced in India as an antibody therapy to treat COVID-positive patients, are being used to minimise mutation formation and should always be used in a pair, said Dr Nirmal K Ganguly, former Director-General of the Indian Cou
New Delhi [India], May 30 (ANI): Monoclonal antibody cocktail, used for the treatment of COVID-19, is unlikely to lead to further mutation of the virus, said Dr Raman R Gangakhedkar, former Head Scientist of Epidemiology and Communicable Diseases at the Indian Council of Medical Research (IC
New Delhi [India], May 30 (ANI): The cost of Monoclonal antibody therapy, which was recently approved by India's top drug regulatory body for treatment of COVID-19, can be lowered if a very efficient system for its manufacturing is developed, said Dr Nirmal K Ganguly, former Director-General
New Delhi [India], May 30 (ANI): Monoclonal antibody drug production in India at reasonable price could be a "game changer" for the country in its fight against COVID-19, said Dr Arvinder S Soin, Chairman, Institute of Liver Transplant and Regenerative Medicine at Medanta Hospital on Sunday.
Chennai (Tamil Nadu) [India], May 28 (ANI/NewsVoir): A new entrant into the treatment portfolio of COVID-19 in India is the cocktail formulation of Mono Clonal Antibodies (MCAb).
New Delhi [India], May 27 (ANI): Zydus Cadila has sought approval from the Drugs Controller General of India (DCGI) to undertake clinical trials for monoclonal antibodies cocktail that can neutralise COVID-19 infection, the pharmaceutical manufacturer informed on Thursday.